ArticleJournal of cancer research and clinical oncology2013

Doxorubicin induces atypical NF-κB activation through c-Abl kinase activity in breast cancer cells.

José Esparza-López et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.